Having optimal cardiovascular health is associated with a reduced risk for mild cognitive impairment among people with type 2 diabetes.

Black patients had a greater likelihood for psychotic and headache disorders after traumatic brain injury than white patients ...

Discover Sangamo Therapeutics’ Q3 2025 highlights: clinical progress in Fabry disease, FDA support for ST-920, extended cash runway, and partnership updates.

Two open-label extension studies show that the FcRn blocker nipocalimab has durable efficacy and sustained symptom control ...

Research suggests that adding more fruits and vegetables to your diet could support sleep. It has to do with fiber and ...

Long-term melatonin use among patients with insomnia is associated with negative cardiac effects, new research suggests.

The new minimally invasive treatment for IVDD is currently only available in the United Kingdom at the University of ...

Q3 2025 Earnings Call Transcript November 6, 2025 Lantheus Holdings, Inc. misses on earnings expectations. Reported EPS is $0 ...

Patients across England are set to gain direct access to specialist care via the NHS App, as dozens of new pilot schemes aim ...

A significant number of the 45 pilots, taking place at 37 trusts across England, will concentrate on five specialisms ...

For most of us, the phrase "stroke of the eye" sounds like a metaphor. But for UK HealthCare's Jagannadha "Jay" Avasarala, M.D., Ph.D., it's a literal ...

It comes as the NHS launches another world-first trial looking at how to support people with motor neurone disease (MND) ...